PhRMA Sues To Block 'Unprecedented' California Price Reporting Law

Ban on WAC price increases violates Commerce Clause and reporting requirement violates First Amendment, PhRMA contends; complaint says state officials have not clarified whether law is retroactive.

court house

Six years after winning a landmark case challenging a Vermont statute's restriction of pharma marketing practices, the Pharmaceutical Research and Manufacturers of America (PhRMA) is seeking to strike down a California law restricting drug company pricing practices.

On Dec. 8, PhRMA filed suit against California Governor Jerry Brown, Jr

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Pricing Debate

More from Market Access